Design of 5' Untranslated Sequences in Retroviral Vectors Developed for Medical Use

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1999 Apr 10

PMID 10196304

Citations 45

Authors

M Hildinger

K L Abel

W Ostertag

C Baum

Affiliations

Soon will be listed here.

Abstract

Utilizing genetic modules of simple retroviruses, we have developed a novel generation of gene transfer vectors with improved therapeutic potential. In the 5' untranslated "leader" sequences, all AUG codons which may aberrantly initiate translation and all viral coding sequences were removed. Thus, the probability of expressing unwanted peptides and the potential for homologous recombination with retroviral genes were largely reduced, and the cloning capacity was increased. The transgene was inserted to replace the viral gag sequences, and a new minimal splice acceptor was introduced, resulting in increased expression with all genes tested (those coding for human multidrug resistance 1 and enhanced green fluorescent protein, as well as the lacZ gene). These vectors may represent attractive tools for human gene therapy, because they increase the efficiency of transgene expression and may also increase safety in medical applications.

Citing Articles

The neuronal transcription factor MEIS2 is a calpain-2 protease target.

Muller T, Reichlmeir M, Hau A, Wittig I, Schulte D J Cell Sci. 2024; 137(4).

PMID: 38305737 PMC: 10941658. DOI: 10.1242/jcs.261482.

CD45-Directed CAR-T Cells with CD45 Knockout Efficiently Kill Myeloid Leukemia and Lymphoma Cells In Vitro Even after Extended Culture.

Harfmann M, Schroder T, Glow D, Jung M, Uhde A, Kroger N Cancers (Basel). 2024; 16(2).

PMID: 38254824 PMC: 10814116. DOI: 10.3390/cancers16020334.

TGF Inhibitor A83-01 Enhances Murine HSPC Expansion for Gene Therapy.

Fleischauer J, Bastone A, Selich A, John-Neek P, Weisskoeppel L, Schaudien D Cells. 2023; 12(15).

PMID: 37566057 PMC: 10416825. DOI: 10.3390/cells12151978.

Retroviral gene therapy in Germany with a view on previous experience and future perspectives.

Morgan M, Galla M, Grez M, Fehse B, Schambach A Gene Ther. 2021; 28(9):494-512.

PMID: 33753908 PMC: 8455336. DOI: 10.1038/s41434-021-00237-x.

Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies.

Schriewer L, Schutze K, Petry K, Hambach J, Fumey W, Koenigsdorf J Theranostics. 2020; 10(6):2645-2658.

PMID: 32194826 PMC: 7052896. DOI: 10.7150/thno.38533.

References

Matsumoto K, Wassarman K, Wolffe A . Nuclear history of a pre-mRNA determines the translational activity of cytoplasmic mRNA. EMBO J. 1998; 17(7):2107-21. PMC: 1170555. DOI: 10.1093/emboj/17.7.2107. View

Schilz A, Brouns G, Knoss H, Ottmann O, Hoelzer D, Fauser A . High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions. Blood. 1998; 92(9):3163-71. View

Hildinger M, ECKERT H, Schilz A, John J, Ostertag W, Baum C . FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells. Gene Ther. 1999; 5(11):1575-9. DOI: 10.1038/sj.gt.3300759. View

Wolff L, Kaminchik J, HANKINS W, Ruscetti S . Sequence comparisons of the anemia- and polycythemia-inducing strains of Friend spleen focus-forming virus. J Virol. 1985; 53(2):570-8. PMC: 254672. DOI: 10.1128/JVI.53.2.570-578.1985. View

Colicelli J, Goff S . Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J Virol. 1986; 57(1):37-45. PMC: 252696. DOI: 10.1128/JVI.57.1.37-45.1986. View

Bender M, Palmer T, Gelinas R, Miller A . Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J Virol. 1987; 61(5):1639-46. PMC: 254146. DOI: 10.1128/JVI.61.5.1639-1646.1987. View

Armentano D, Yu S, Kantoff P, von Ruden T, Anderson W, Gilboa E . Effect of internal viral sequences on the utility of retroviral vectors. J Virol. 1987; 61(5):1647-50. PMC: 254147. DOI: 10.1128/JVI.61.5.1647-1650.1987. View

Miller A, Rosman G . Improved retroviral vectors for gene transfer and expression. Biotechniques. 1989; 7(9):980-2, 984-6, 989-90. PMC: 1360503. View

Miller A, Miller D, Garcia J, Lynch C . Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 1993; 217:581-99. DOI: 10.1016/0076-6879(93)17090-r. View

10.

Mulligan R . The basic science of gene therapy. Science. 1993; 260(5110):926-32. DOI: 10.1126/science.8493530. View

11.

Anderson W, McGarrity G, Moen R . Report to the NIH Recombinant DNA Advisory Committee on murine replication-competent retrovirus (RCR) assays (February 17, 1993). Hum Gene Ther. 1993; 4(3):311-21. DOI: 10.1089/hum.1993.4.3-311. View

12.

Portis J, Spangrude G, McAtee F . Identification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus. J Virol. 1994; 68(6):3879-87. PMC: 236893. DOI: 10.1128/JVI.68.6.3879-3887.1994. View

13.

Otto E, Vanin E, Stambaugh K, Mueller S, Anderson W, McGarrity G . Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. Hum Gene Ther. 1994; 5(5):567-75. DOI: 10.1089/hum.1994.5.5-567. View

14.

Boeck R, Kolakofsky D . Positions +5 and +6 can be major determinants of the efficiency of non-AUG initiation codons for protein synthesis. EMBO J. 1994; 13(15):3608-17. PMC: 395266. DOI: 10.1002/j.1460-2075.1994.tb06668.x. View

15.

BERLIOZ C, Darlix J . An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors. J Virol. 1995; 69(4):2214-22. PMC: 188890. DOI: 10.1128/JVI.69.4.2214-2222.1995. View

16.

Riviere I, Brose K, Mulligan R . Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci U S A. 1995; 92(15):6733-7. PMC: 41403. DOI: 10.1073/pnas.92.15.6733. View

17.

Baum C, Hegewisch-Becker S, ECKERT H, Stocking C, Ostertag W . Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J Virol. 1995; 69(12):7541-7. PMC: 189692. DOI: 10.1128/JVI.69.12.7541-7547.1995. View

18.

Berkowitz R, Fisher J, Goff S . RNA packaging. Curr Top Microbiol Immunol. 1996; 214:177-218. DOI: 10.1007/978-3-642-80145-7_6. View

19.

ECKERT H, Stockschlader M, Just U, Hegewisch-Becker S, Grez M, Uhde A . High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood. 1996; 88(9):3407-15. View

20.

Krall W, Skelton D, Yu X, Riviere I, Lehn P, Mulligan R . Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells. Gene Ther. 1996; 3(1):37-48. View